These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35608304)

  • 1. COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases.
    Cardelli C; Caruso T; Tani C; Pratesi F; Talarico R; Di Cianni F; Italiano N; Laurino E; Moretti M; Cascarano G; Diomedi M; Gualtieri L; D'Urzo R; Migliorini P; Mosca M
    Rheumatology (Oxford); 2022 Nov; 61(11):e328-e330. PubMed ID: 35608304
    [No Abstract]   [Full Text] [Related]  

  • 2. BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study.
    Bieber A; Sagy I; Novack L; Brikman S; Abuhasira R; Ayalon S; Novofastovski I; Abu-Shakra M; Mader R
    Ann Rheum Dis; 2022 Jul; 81(7):1028-1035. PubMed ID: 35418481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series.
    Furer V; Zisman D; Kibari A; Rimar D; Paran Y; Elkayam O
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI90-SI95. PubMed ID: 33848321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving COVID-19 Vaccine Coverage in Patients With Autoimmune and Inflammatory Diseases.
    Goulenok T; Francois C; Mendes C; Farhi F; Alexandra JF; Rouzaud D; Papo T; Sacre K
    J Rheumatol; 2022 Jan; 49(1):118-119. PubMed ID: 34654731
    [No Abstract]   [Full Text] [Related]  

  • 5. The Use of COVID-19 Vaccines in Patients with SLE.
    Tang W; Gartshteyn Y; Ricker E; Inzerillo S; Murray S; Khalili L; Askanase A
    Curr Rheumatol Rep; 2021 Nov; 23(11):79. PubMed ID: 34767100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.
    Furer V; Eviatar T; Zisman D; Peleg H; Paran D; Levartovsky D; Zisapel M; Elalouf O; Kaufman I; Meidan R; Broyde A; Polachek A; Wollman J; Litinsky I; Meridor K; Nochomovitz H; Silberman A; Rosenberg D; Feld J; Haddad A; Gazzit T; Elias M; Higazi N; Kharouf F; Shefer G; Sharon O; Pel S; Nevo S; Elkayam O
    Ann Rheum Dis; 2021 Oct; 80(10):1330-1338. PubMed ID: 34127481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines.
    Fan Y; Geng Y; Wang Y; Deng X; Li G; Zhao J; Ji L; Zhang X; Song Z; Zhang H; Sun X; Gao D; Xie W; Huang H; Hao Y; Zhang Z
    Ann Rheum Dis; 2022 Mar; 81(3):443-445. PubMed ID: 34824048
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology.
    Park JK; Lee EB; Shin K; Sung YK; Kim TH; Kwon SR; Lee MS; Hong SJ; Choi BY; Lee SS; Back HJ;
    J Korean Med Sci; 2021 Mar; 36(12):e95. PubMed ID: 33783147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
    Furer V; Rondaan C; Agmon-Levin N; van Assen S; Bijl M; Kapetanovic MC; de Thurah A; Mueller-Ladner U; Paran D; Schreiber K; Warnatz K; Wulffraat NM; Elkayam O
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases.
    Cook C; Patel NJ; D'Silva KM; Hsu TY; DiIorio M; Prisco L; Martin LW; Vanni K; Zaccardelli A; Todd D; Sparks JA; Wallace ZS
    Ann Rheum Dis; 2022 Feb; 81(2):289-291. PubMed ID: 34489304
    [No Abstract]   [Full Text] [Related]  

  • 11. Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy.
    Vanni KM; Patel NJ; DiIorio M; Kowalski E; Qian G; Cook CE; Ritter SY; Wallace ZS; Sparks JA
    RMD Open; 2022 Feb; 8(1):. PubMed ID: 35110366
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study.
    Esquivel-Valerio JA; Skinner-Taylor CM; Moreno-Arquieta IA; Cardenas-de la Garza JA; Garcia-Arellano G; Gonzalez-Garcia PL; Almaraz-Juarez FDR; Galarza-Delgado DA
    Rheumatol Int; 2021 Dec; 41(12):2105-2108. PubMed ID: 34622311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.
    Boyarsky BJ; Ruddy JA; Connolly CM; Ou MT; Werbel WA; Garonzik-Wang JM; Segev DL; Paik JJ
    Ann Rheum Dis; 2021 Aug; 80(8):1098-1099. PubMed ID: 33757968
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease.
    Mehta P; Paul A; Ahmed S; Cherian S; Panthak A; Benny J; Shenoy P
    Clin Rheumatol; 2022 Nov; 41(11):3537-3542. PubMed ID: 35760938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases.
    Fragoulis GE; Karamanakos A; Arida A; Bournia VK; Evangelatos G; Fanouriakis A; Fragiadaki K; Kravvariti E; Laskari K; Panopoulos S; Papazoglou N; Pappa M; Tektonidou MG; Sfikakis PP
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35246472
    [No Abstract]   [Full Text] [Related]  

  • 16. Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases.
    Felten R; Dubois M; Ugarte-Gil MF; Chaudier A; Kawka L; Bergier H; Costecalde C; Pijnenburg L; Fort J; Chatelus E; Sordet C; Javier RM; Gottenberg JE; Sibilia J; Fuentes-Silva YJ; Arnaud L
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI68-SI76. PubMed ID: 33983432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covid-19 vaccination in autoimmune rheumatic diseases: A multi-center survey from southern India.
    Mohanasundaram K; Santhanam S; Natarajan R; Murugesan H; Nambi T; Chilikuri B; Nallasivan S
    Int J Rheum Dis; 2022 Sep; 25(9):1046-1052. PubMed ID: 35773944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'.
    Smerilli G; Cipolletta E; Moscioni E; Francioso F; Risa AM; Maccarrone V; Zompa D; Di Matteo A; Di Carlo M; De Angelis R; Salaffi F; Filippucci E; Grassi W
    Ann Rheum Dis; 2021 Oct; 80(10):e168. PubMed ID: 33962960
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to: 'Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'' by Smerilli
    Priori R; Pellegrino G; Colafrancesco S; Alessandri C; Ceccarelli F; Di Franco M; Riccieri V; Scrivo R; Sili Scavalli A; Spinelli FR; Conti F
    Ann Rheum Dis; 2021 Oct; 80(10):e169. PubMed ID: 33962963
    [No Abstract]   [Full Text] [Related]  

  • 20. Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic Diseases.
    Hazlewood GS; Pardo JP; Barnabe C; Schieir O; Barber CEH; Bernatsky S; Colmegna I; Hitchon C; Loeb M; Mertz D; Proulx L; Richards DP; Scuccimarri R; Tugwell P; Schünemann HJ; Mirza RD; Zhou AL; Nikolic RPA; Thomas M; Chase H; Ejaredar M; Nieuwlaat R
    J Rheumatol; 2021 Aug; 48(8):1330-1339. PubMed ID: 33993119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.